SynthesisFrontiers in pharmacology2024

Confirming the efficacy and safety of CDK4/6 inhibitors in the first-line treatment of HR+ advanced breast cancer: a systematic review and meta-analysis.

Xin Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.